Corbin, AS, O'Hare, T, Gu, Z, Kraft, IL, Eiring, AM, Khorashad, JS, Pomicter, AD, Zhang, TY, Eide, CA, Manley, PW, Cortes, JE, Druker, BJ and Deininger, MW (2013) KIT Signaling Governs Differential Sensitivity of Mature and Primitive CML Progenitors to Tyrosine Kinase Inhibitors. CANCER RESEARCH. pp. 5775-5786.

Item Type:	Article
Additional Information:	pubid: 131 nvp_institute: NIBR contributor_address: Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA, Howard Hughes Med Inst, Chevy Chase, MD USA ; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA, Univ Utah, Div Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA michael.deininger@hci.utah.edu; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA ; Novartis Inst BioMed Res, Basel, Switzerland ; Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA ; Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA; Howard Hughes Med Inst, Chevy Chase, MD USA; Deininger, M W; Univ Utah, Huntsman Canc Inst, 2000 Circle Hope,Room 4280, Salt Lake City, UT 84112 USA
Date Deposited:	13 Oct 2015 13:12
Last Modified:	13 Oct 2015 13:12
URI:	https://oak.novartis.com/id/eprint/21966